Macroamylasemia: Difference between revisions
No edit summary |
No edit summary |
||
| Line 21: | Line 21: | ||
Macroamylasemia has been associated with: | Macroamylasemia has been associated with: | ||
* Celiac disease | * [[Celiac disease]] | ||
* HIV infection | * [[HIV infection]] | ||
* Lymphoma | * [[Lymphoma]] | ||
* Monoclonal gammopathy | * [[Monoclonal gammopathy]] | ||
* Rheumatoid arthritis | * [[Rheumatoid arthritis]] | ||
* Ulcerative colitis | * [[Ulcerative colitis]] | ||
{{Symptoms and signs}} | {{Symptoms and signs}} | ||
Revision as of 16:37, 9 January 2009
| Macroamylasemia |
|
WikiDoc Resources for Macroamylasemia |
|
Articles |
|---|
|
Most recent articles on Macroamylasemia Most cited articles on Macroamylasemia |
|
Media |
|
Powerpoint slides on Macroamylasemia |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Macroamylasemia at Clinical Trials.gov Trial results on Macroamylasemia Clinical Trials on Macroamylasemia at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Macroamylasemia NICE Guidance on Macroamylasemia
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Macroamylasemia Discussion groups on Macroamylasemia Patient Handouts on Macroamylasemia Directions to Hospitals Treating Macroamylasemia Risk calculators and risk factors for Macroamylasemia
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Macroamylasemia |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Macroamylasemia is a benign acquired condition, characterized by a serum amylase unusually large in molecular size that has been found to occur in apparently healthy humans as well as in a variety of diseases including liver disease, diabetes, cancer, malabsorption and autoimmune disorders. Most commonly macroamylasemia results from the formation of immune complexes between amylase and immunoglobulins.
Macroamylasemia has been associated with:
Template:Skin and subcutaneous tissue symptoms and signs Template:Nervous and musculoskeletal system symptoms and signs Template:Urinary system symptoms and signs Template:Cognition, perception, emotional state and behaviour symptoms and signs Template:Speech and voice symptoms and signs Template:General symptoms and signs